Pay in 4 interest-free payments of $5.77 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
These effects can contribute to improved metabolic efficiency
Safety considerations: GLP-1 receptor agonists are contraindicated in patients with personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2
For a detailed comparison of research outcomes between tirzepatide and retatrutide, see the tirzepatide vs retatrutide research outcomes analysis
Provider Access & Oversight Does the platform require a live video doctor or rely only on questionnaires
US$ 26.09
US$ 20.96
US$ 26.57
US$ 26.72
US$ 28.84
US$ 21.88
US$ 23.91
